The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
Salomon M. Stemmer, Shmuel H. Klang, Noa Ben-Baruch, David B. Geffen, Mariana Steiner, Lior Soussan-Gutman, Shahar Merling, Christer Svedman, Shulamith Rizel, Nicky Lieberman
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients'. Together they form a unique fingerprint.